CAS: 1025821-33-3
GSK-626616
CAS:1025821-33-3
GSK-626616: strong, oral DYRK3 inhibitor (IC50: 0.7 nM), affects DYRK family, may treat anemia.
Formula:
C18H10Cl2N4OS
Purity:
99.48%
Color and Shape:
Solid
Molecular weight:
401.27
Ref: TM-T15422
| 1mg | 52.00 € | ||
| 5mg | 94.00 € | ||
| 10mg | 149.00 € | ||
| 25mg | 275.00 € | ||
| 50mg | 508.00 € | ||
| 100mg | 733.00 € | ||
| 1mL*10mM (DMSO) | 95.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
![(5Z)-2-[(2,6-Dichlorophenyl)amino]-5-(6-quinoxalinylmethylene)-4(5H)-thiazolone](https://static.cymitquimica.com/products/IN/thumb/DA01ENHC.jpg)
(5Z)-2-[(2,6-Dichlorophenyl)amino]-5-(6-quinoxalinylmethylene)-4(5H)-thiazolone
CAS:1025821-33-3
Formula:
C18H10Cl2N4OS
Purity:
98%
Color and Shape:
Solid
Molecular weight:
401.2692
Ref: IN-DA01ENHC
| 1mg | 127.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
GSK 626616
CAS:1025821-33-3
Potent inhibitor of dual specificity tyrosine-phosphorylation-regulated kinase 3 (DYRK3) with IC50 value of 0.7 nM. …
Formula:
C18H10Cl2N4OS
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
401.27 g/mol
Ref: 3D-BG166664
| 25mg | 372.00 € | ||
| 50mg | 556.00 € | ||
| 100mg | 887.00 € | ||
| 250mg | 1,738.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
GSK 626616 - Bio-X ™
CAS:1025821-33-3
This product is part of our Bio-X ™ Range. These products are aimed at life …
Formula:
C18H10Cl2N4OS
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
401.27 g/mol
Ref: 3D-BG300011
| 10mg | 232.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
GSK-626616
Controlled ProductCAS:1025821-33-3
Applications GSK-626616 is a potent and selective DYRK inhibitor (IC50 = 0.7 nM for DYRK3, …
Formula:
C18H10Cl2N4OS
Color and Shape:
Yellow
Molecular weight:
401.27
Ref: TR-G797853
| 5mg | 147.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
